Surprising RNA discovery
Social coverage highlighted a surprise RNA discovery that challenges prior assumptions about gene function, with SciTechDaily sourcing the initial report. (x.com) The findings circulated on X with commentary suggesting some gene roles may need to be reconsidered. (x.com)
Cells make RNA as a working copy of DNA, and one newly described RNA appears to do a second job inside a gene long treated as protein-only. In a paper accepted by the Proceedings of the National Academy of Sciences on December 8, 2025, researchers at Texas A&M reported an RNA called CUL1-IPA from the CUL1 gene locus. The study says this RNA is made by intronic polyadenylation, a process that cuts an RNA early and gives it a tail before it becomes the usual full-length message. That matters because biology textbooks usually start with a simpler path: DNA is copied into messenger RNA, and messenger RNA is read into protein. Reviews in Nature in 2023 and 2024 said that picture already had many exceptions, with large numbers of non-coding RNAs and some genes producing both coding and non-coding products. The Texas A&M team says CUL1-IPA stays in the nucleus instead of leaving to help make CUL1 protein. It moves to the nucleolus, the dense structure that makes ribosomes, which are the cell’s protein-building machines. When the researchers removed CUL1-IPA from living cells, the nucleolus lost its structure and the cells showed stress. The paper also says ribosomal RNA levels fell, overall protein synthesis dropped, and cells accumulated in the G2/M stage of the cell cycle. The study identified two nucleolar binding partners, GPATCH4 and NOP58, for the RNA. The authors say putting CUL1-IPA back into cells reversed the drop in ribosomal RNA, which tied the molecule to nucleolar function rather than treating it as a byproduct. The cancer angle came from patient datasets, not a clinical trial. Texas A&M said the group examined multiple myeloma and chronic lymphocytic leukemia data and found higher CUL1-IPA levels in patients with more severe disease, while the PNAS paper says reduced CUL1-IPA expression was associated with improved survival outcomes. The larger point is narrower than “genes were misunderstood” and more specific than social posts often suggest. This paper adds one concrete example to a growing body of evidence that a protein-coding gene can also produce a non-coding RNA with its own cellular role. For now, the finding is a lab result and a patient-data association, not a new treatment. But it gives researchers one more reason to look at the RNA products cut from familiar genes before assuming those transcripts are just incomplete messages.
